1)Uchiyama T, et al:Adult T-cell leukemia;Clinical and hematologic features of 16 cases. Blood 50:481-492, 1977
2)Satake M, et al:Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol 84:327-335, 2012
3)Vassilakopoulos TP, Pangalis GA:Application of a prediction rule to select which patients presenting with lymphadenopathy should undergo a lymph node biopsy. Medicine(Baltimore)79:338-347, 2000
4)Tokuda Y, et al:Assessing the validity of a model to identify patients for lymph node biopsy. Medicine(Baltimore)82:414-418, 2003
5)Gaddey HL, Riegel AM:Unexplained lymphadenopathy;Evaluation and differential diagnosis. Am Fam Physician 94:896-903, 2016
6)Klein A, et al:Rheumatoid arthritis and lymphoma;Incidence, pathogenesis, biology, and outcome. Hematol Oncol 36:733-739, 2018
7)Lymphoma Study Group of Japanese Pathologists:The World Health Organization classification of malignant lymphomas in Japan;Incidence of recently recognized entities. Pathol Int 50:696-702, 2000
8)Katsuya H, et al:Treatment and survival among 1594 patients with ATL. Blood 126:2570-2577, 2015